Vimarsana
Biggest News Aggregation in the World

Rosetta Genomics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rosetta Genomics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rosetta Genomics Today - Breaking & Trending Today

Rosetta Genomics To Present At Maxim Group Growth Conference - Vimarsana News

Rosetta Genomics To Present At Maxim Group Growth Conference

REHOVOT, Israel and JERSEY CITY, New Jersey, September 24 /PRNewswire/ -- Rosetta Genomics Ltd (Nasdaq:ROSG), a leader in the development of microRNA-based diagnostics, announced today its management will present at the Maxim Group Growth Conference in New York City on Tuesday, October 7, 2008.

Global Pharma, Biotech & Diagnostics Co-promotion and - Vimarsana News

Global Pharma, Biotech & Diagnostics Co-promotion and

Dublin, April 20, 2023 (GLOBE NEWSWIRE) -- The "Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech & Diagnostics...

Insights Into The Global Kidney Cancer Drugs Market 2022-2031 Forecast Period - Vimarsana News

Insights Into The Global Kidney Cancer Drugs Market 2022-2031 Forecast Period

The Business Research Company’s Kidney Cancer Drugs Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026

Lucid Diagnostics' (LUCD) CEO Lishan Aklog on Q1 2022 Results - Earnings Call Transcript - Vimarsana News

Lucid Diagnostics' (LUCD) CEO Lishan Aklog on Q1 2022 Results - Earnings Call Transcript

Lucid Diagnostics Inc. (NASDAQ:NASDAQ:LUCD) Q1 2022 Earnings Conference Call May 11, 2022 4:30 PM ET Company Participants Adrian Miller – Vice President-Investor Relations Lishan Aklog –...

Demand For Colorectal Cancer Diagnostics Is Expected To Rise At A CAGR Of 8.5% Over The Decade - Vimarsana News

Demand For Colorectal Cancer Diagnostics Is Expected To Rise At A CAGR Of 8.5% Over The Decade

According to Fact.MR, a market research and competitive intelligence provider, the global colorectal cancer diagnostics market is anticipated to rise at a robust CAGR of 8.5% over the next ten years. As per this study, the market was valued at around US$ 2 Bn in 2020, and is anticipated to expand 2.2X by the end of...